Company

CytomX Therapeutics

Rocket Ship Rating

Rocket Ship Rating: 96 out of 100

Destroying Cancer, Differently

Also known as CytomX Therapeutics, Inc.

Biotech & therapeutics

Status: Operatingas of 2026-09-17
Business model: B2B
Headquarters: South San Francisco, California, United States
Legal name: CytomX Therapeutics, Inc.

Open relationship map

Claim, correct or request removal

Record updated 28 September 2026

About

CytomX is a different kind of clinical-stage biopharmaceutical company – intent on revolutionizing the way we treat cancer.

Funding snapshot

Total raised: $143MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
Latest round: Round, $30M2023-06-29

Funding rounds

Round, 2023: $30M2023-06-29, SEC form D sold, 4 investors
Round, 2015: $70M2015-06-12, SEC form D sold, 33 investors
Round, 2014: $16.5M2014-12-22, SEC form D sold, 4 investors
Round, 2012: $12.6M2012-07-26, SEC form D sold, 3 investors
Round, 2010: $653K2010-09-22, SEC form D sold, 1 investor
Round, 2010: $102K2010-09-22, SEC form D sold, 1 investor
Round, 2010: $10M2010-09-22, SEC form D sold, 2 investors
Round, 2010: $525K2010-09-22, SEC form D sold, 19 investors
Round, 2010: $2.7M2010-09-22, SEC form D sold, 1 investor